A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Clinical trial NCT02255110 · TERMINATED
Trial details
- NCT number
- NCT02255110
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-10
- Primary completion
- 2016-01-12
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.